EXODIAB: Excellence of Diabetes Research in Sweden
1 – 10 of 4060
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Precision prognostics for cardiovascular disease in Type 2 diabetes : a systematic review and meta-analysis
(
- Contribution to journal › Article
-
Mark
Reply to 'Graded exercise therapy should not be recommended for patients with post-exertional malaise'
2024) In Nature Reviews Cardiology(
- Contribution to journal › Letter
-
Mark
Pulmonary function and atherosclerosis in the general population : causal associations and clinical implications
(
- Contribution to journal › Article
-
Mark
Brain energy metabolism : A roadmap for future research
2024) In Journal of Neurochemistry(
- Contribution to journal › Article
-
Mark
Reply to “Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients”
(
- Contribution to journal › Letter
-
Mark
Emerging role of microRNAs as regulators of protein kinase C substrate MARCKS and MARCKSL1 in cancer
(
- Contribution to journal › Scientific review
-
Mark
Low-level exposure to lead and atherosclerosis in the carotid arteries : Results from the Swedish population-based cohort SCAPIS
(
- Contribution to journal › Article
-
Mark
Detecting potential outliers in longitudinal data with time-dependent covariates
2024) In European Journal of Clinical Nutrition(
- Contribution to journal › Article
-
Mark
Randomized open-label trial of semaglutide and dapagliflozin in patients with type 2 diabetes of different pathophysiology
(
- Contribution to journal › Article
-
Mark
Plasma levels of PRO-C3, a type III collagen synthesis marker, are associated with arterial stiffness and increased risk of cardiovascular death
(
- Contribution to journal › Article